• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by VSee Health Inc.

    3/31/25 9:15:57 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email
    NT 10-K 1 tm2511015d1_nt10k.htm NT 10-K

     

    SEC FILE NUMBER: 001-41015

    CUSIP NUMBER: 92919Y102

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K  
      ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR

     

    For Period Ended: December 31, 2024

     

      ¨ Transition Report on Form 10-K
      ¨ Transition Report on Form 20-F
      ¨ Transition Report on Form 11-K
      ¨ Transition Report on Form 10-Q
      ¨ Transition Report on Form N-SAR
         
        For the Transition Period Ended:
         
         

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

     

     

    PART I -- REGISTRANT INFORMATION

     

    VSEE HEALTH, INC.

    Full Name of Registrant

     

    N/A

    Former Name if Applicable

     

    980 N Federal Hwy #304

    Address of Principal Executive Office (Street and Number)

     

    Boca Raton, FL 33432

    City, State and Zip Code

     

     

     

     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

     

    x (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III - NARRATIVE

     

    State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

     

    VSee Health, Inc. (the “Company”) could not timely file without unreasonable effort or expense its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) because it requires additional time to compile audited financial statements in connection with the de-SPAC merger closed in June 2024. The Company is working diligently with the auditor to complete its Form 10-K and the Form 10-K review as soon as possible and currently expects to file the Form 10-K within the fifteen-day extension period provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

     

    PART IV - OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification:

     

     

    Jerry Leonard

    Chief Financial Officer

     

    516

     

    672-7068

     
      Name (Area Code) (Telephone Number)  

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
      x Yes ¨ No
       
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
      ¨ Yes x No

     

    If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

     

    VSEE HEALTH, INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: March 31, 2025 By: /s/ Jerry Leonard
        Name: Jerry Leonard
        Title: Chief Financial Officer

     

     

    Get the next $VSEE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    SEC Filings

    See more
    • SEC Form 8-K filed by VSee Health Inc.

      8-K - VSEE HEALTH, INC. (0001864531) (Filer)

      5/30/25 5:01:08 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by VSee Health Inc.

      8-K - VSEE HEALTH, INC. (0001864531) (Filer)

      5/8/25 5:04:24 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-K filed by VSee Health Inc.

      NT 10-K - VSEE HEALTH, INC. (0001864531) (Filer)

      3/31/25 9:15:57 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

      VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

      5/30/25 4:07:00 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines

      VSee Health, Inc. (NASDAQ:VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516245654/en/Local clinic staff performs a prenatal checkup using the VSee telemedicine kit and digital health platform. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga

      5/16/25 8:23:00 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

      VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market. According to the notice, the Company has 60 calendar days

      5/12/25 4:10:00 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Financials

    Live finance-specific insights

    See more
    • VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

      12/20/24 9:00:00 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

      12/2/24 4:05:00 PM ET
      $SXTP
      $VSEE
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Nursing Services

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

      SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

      11/14/24 8:45:14 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

      SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

      11/14/24 5:23:34 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by VSee Health Inc.

      SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

      7/5/24 4:29:01 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Maxim Group initiated coverage on VSee Lab with a new price target

      Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

      2/24/25 8:42:03 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-CEO Aisiku Imoigele disposed of 120,000 shares, decreasing direct ownership by 3% to 3,416,990 units (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      11/19/24 8:57:01 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Large owner Sands Lawrence M. acquired $405,000 worth of shares (202,500 units at $2.00) (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      11/19/24 8:55:08 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Large owner Sands Lawrence M. acquired 2,500 shares (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      8/26/24 6:00:12 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care